Vanguard crLyme (Canada)

Company: Zoetis

Borrelia Burgdorferi Bacterial Extract

For use in dogs only

This product has been shown to be effective for the vaccination of healthy dogs 8 weeks of age or older against Borrelia burgdorferi. Duration of immunity of at least 15 months has been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Directions For Use

Shake well and aseptically administer 1 mL subcutaneously. Healthy dogs should receive 2 doses administered 3 weeks apart. Historically, annual revaccination with this product was recommended. The need for annual revaccination has not been established; consultation with your veterinarian or the manufacturer is recommended. If a different product was previously used to vaccinate against Borrelia burgdorferi, the dog should receive the two dose protocol to maximize protection.

Precautions

Store at 2°-8°C. Do not freeze. Use entire contents when first opened. Sterilized syringes and needles should be used to administer this vaccine. Vaccination of pregnant bitches should be avoided. In case of anaphylaxis, administer epinephrine or equivalent. Do not mix with other products. In case of human exposure, contact a physician.

Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (800) 461-0917.

This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.

U.S. Veterinary License No. 190

Zoetis Inc., Kalamazoo, MI 49007, USA

CPN: 1198529.1